학술논문
208TiP SOLTI-1303 PATRICIA: Cohort C. Combination of palbociclib with trastuzumab and endocrine therapy (ET) versus treatment of physician’s choice (TPC) in pretreated HER2-positive and hormone receptor-positive (HER2+/HR+) / PAM50 luminal metastatic breast cancer (BC): A randomized phase II trial
Document Type
Abstract
Author
Ciruelos, E.M.; Ponce, J.; Pernas Simon, S.; Cortés, J.; Cantos, B.; Garate, E.; Vega Alonso, E.; Mele Olive, M.; Martinez De Dueñas, E.; Montaño Perianez, A.; Martinez, N.; Perello Martorell, A.; Bermejo De Las Heras, B.; Arqueros Nunez, C.; Fernández, I.; De la Haba Rodriguez, J.; Oliveira, M.; González, X.; Villagrasa Gonzalez, P.; Prat, A.
Source
In Annals of Oncology May 2022 33 Supplement 3:S222-S223
Subject
Language
ISSN
0923-7534